Genpharmasec Corporate Filings & Announcements

Latest corporate announcements and filings from Genpharmasec on BSE

Search Inside the pdf :

Genpharmasec Ltd.

13 May 2026

1.16

4.50%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held …

BSE India

Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1. To consider, approve & take on record the Audited Standalone and Consolidated Financial Results of the Company along with the Auditor's Report thereon, for the Quarter and Year ended 31st March, 2026. 2. To consider any other business with the permission of a Chairman of the Meeting.

pdf

Genpharmasec Ltd.

14 Apr 2026, 03:45PM

1.16

4.50%

Corp. Note

Genpharmasec Ltd - 531592 - Format of the Initial Disclosure to be made by an entity …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyGenpharmasec Ltd 2CIN NO.L24231MH1992PLC323914 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Hardik Makwana Designation: Company Secretary and Compliance Officer EmailId: compliance@genpharmasec.com Name of the Chief Financial Officer: Mr Sohan Chaturvedi Designation: Chief Financial Officer EmailId: Sohan.chaturvedi@genpharmasec.com Date: 14/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Genpharmasec Ltd.

08 Apr 2026

1.16

4.50%

Company Update

Genpharmasec Ltd - 531592 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended March 31, 2026.

pdf

Genpharmasec Ltd.

26 Mar 2026

1.16

4.50%

SAST

Genpharmasec Ltd - 531592 - Closure of Trading Window

BSE India

Intimation of closure of Trading window.

pdf

Genpharmasec Ltd.

11 Feb 2026

1.16

4.50%

Company Update

Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of Unaudited Financial Result for the quarter ended December 31, 2025.

pdf

Genpharmasec Ltd.

09 Feb 2026

1.16

4.50%

Company Update

Genpharmasec Ltd - 531592 - Statement Of Deviation Or Variation In The Use Of Proceeds Of …

BSE India

Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 31st December, 2025.

pdf

Genpharmasec Ltd.

09 Feb 2026

1.16

4.50%

Result

Genpharmasec Ltd - 531592 - Unaudited Standalone & Consolidated Financial Result Of The Company For The …

BSE India

Unaudited Standalone & Consolidated Financial Result of the company for the quarter ended December 31, 2025.

pdf

Genpharmasec Ltd.

09 Feb 2026

1.16

4.50%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of …

BSE India

Outcome of the Meeting of Board of Directors held on Monday, February 09, 2026.

pdf

Genpharmasec Ltd.

02 Feb 2026

1.16

4.50%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held …

BSE India

Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter ended 31st December, 2025; 2. To consider any other business Matter with the permission of a Chairman.

pdf

Genpharmasec Ltd.

06 Jan 2026

1.16

4.50%

Company Update

Genpharmasec Ltd - 531592 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories & Participants) Regulation, 2018 for the quarter ended December 31, 2025.

pdf

Is Generic Pharmasec Ltd. worth buying?

111 Votes:

Buy 81.98%

Sell 7.21%

Hold 10.81%